草榴社区

新型药物递送系统，重点围绕靶向制剂、刺激响应缓控释制剂、纳米制剂等方向。

1.Smart nanoparticles for cancer therapy. Signal Transduct Target Ther, 2023, 8(1), 418.
2.Remodeling the tumor immune microenvironment via siRNA therapy for precision cancer treatment. Asian J Pharm Sci. 2023;18(5):100852.
3.β-cyclodextrin derived full-spectrum fluorescent carbon dots: The formation process investigation and biological applications. Chinese Chem Lett, 2023, 34(10): 108239.
4.Local delivery of gambogic acid to improve anti-tumor immunity against oral squamous cell carcinoma, J Control Release, 2022, 351: 381-393.
5.Biomaterial-assisted biotherapy: A brief review of biomaterials used in drug delivery, vaccine development, gene therapy, and stem cell therapy. Bioact Mater, 2022, 19,17:29-48.
6.Regulation of tumor microenvironment for pancreatic cancer therapy. Biomaterials, 2021,270: 120680.
7.Two-dimensional quantum dots for biological applications. Nano Res, 2021, 14: 3820-3839.
8.Identification and Characterisation of Mammaglobin-A Epitope in Heterogenous Breast Cancers for Enhancing Tumor-Targeting Therapy. Signal Transduct Target Ther, 2020, 5, 82.
9.Endo/lysosome-escapable Delivery Depot for Improving BBB Transcytosis and Neuron Targeted Therapy of Alzheimer's Disease. Adv Funct Mater, 2020, 30(27): 1909999.
10.Red/orange dual-emissive carbon dots for pH sensing and cell imaging. Nano Res, 2019, 12:815–821.

主持国家自然科学基金、四川省杰出青年基金、四川省自然科学基金创新研究群体、四川省重大科技专项等十余项国家及省部级科研项目。目前以一作/通讯（含共同）在 J Control Release，Signal Transduct Target Ther，Adv Funct Mater，Biomaterials和Small等发表学术论文34篇；被Nat Rev Mater，Adv Drug Deliv Rev, ACS Nano, Nano lett等杂志引用3200余次，单篇最高被引429次，8篇引用超过100次, 3 篇入选ESI 高被引论文，2 篇被选作封面论文，入选英国 RSC Top 1%高被引中国学者。获国家发明专利授权8项。
代表性科研项目：
1.国家自然科学基金委员会, HEX-FLASH，2023-2025，主持;
2.国家自然科学基金委员会,2015-2017，主持;
3.四川省科学技术厅, 2024-20267，主持;
4.四川省科学技术厅，四川省重大科技专项, 2020-2023，主持;
5.四川省科学技术厅，中央引导地方科技发展资金面上项目, 2023-2025, 主持；
6. 四川省中医药管理局, 中医药科研专项, 2018-2020, 主持；
7. 四川省科学技术厅, “青年基金”计划项目, 2016-2019, 主持。